cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
YCBD.PRA was delisted on the 5th of May, 2025.
5 hedge funds and large institutions have $914K invested in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
39% more capital invested
Capital invested by funds: $658K → $914K (+$256K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
29% less funds holding
Funds holding: 7 → 5 (-2)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$799 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CP
Camelot Portfolios
Maumee,
Ohio
|
-$99K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$96.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$31K |
YCBD.PRA Hedge Fund Activity: Q4 2022 in Review
5 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) for Q4 2022, worth a combined $914K — up 39% from $658K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of YCBD.PRA and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, adding an estimated $799. The largest seller was Camelot Portfolios, exiting entirely with an estimated $99K sold.
- 5 institutional investors held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) as of Q4 2022, down from 7 in Q3 2022.
- Funds reported $914K of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock stock for Q4 2022, up 39% quarter-over-quarter.
- 1 fund opened new cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock positions in Q4 2022 and 2 closed out, a net change of -1 holder.
- The largest cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock buyer in Q4 2022 was Morgan Stanley, an estimated $799 added.
- The largest cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock seller in Q4 2022 was Camelot Portfolios, an estimated $99K sold.
Based on aggregated 13F filings for Q4 2022.